Diabetes may worsen quality of life during cancer treatment, study aims to find out

NCT ID NCT07466212

First seen Mar 21, 2026 · Last updated May 12, 2026 · Updated 7 times

Summary

This study looks at whether having type 2 diabetes makes quality of life worse for cancer patients receiving immunotherapy. About 920 adults with solid tumors will fill out surveys at the start, then at 3 and 6 months. The goal is to see if diabetes adds extra challenges during cancer treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Afdeling for Kræftbehandling, Herlev Hospital

    Herlev, 2730, Denmark

    Contact Email: •••••@•••••

  • Kræftafdelingen, Aarhus Universitetshospital

    Aarhus, 8000, Denmark

    Contact

    Contact Email: •••••@•••••

  • Onkologisk afdeling, Klinik Kirurgi og Kræftbehandling

    Aalborg, 9000, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Sygehus Lillebælt, Onkologisk afdeling Vejle

    Vejle, 7100, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.